US Stock MarketDetailed Quotes

BCDAW Biocardia Inc C/Wts 06/08/2024(To Pur Com)

Watchlist
  • 0.0061
  • 0.00000.00%
Close Aug 2 16:00 ET
0Market Cap0.00P/E (TTM)

About Biocardia Inc C/Wts 06/08/2024(To Pur Com) Company

BioCardia Inc is a clinical-stage company developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases with significant unmet medical needs. Its two cell therapy platforms derived from the bone marrow.  CardiAMP® autologous mononuclear cell therapy platform is being advanced for two clinical indications: ischemic heart failure with reduced ejection fraction (HFrEF) and refractory angina resulting from chronic myocardial ischemia (CMI). Its immunomodulatory allogeneic mesenchymal stem cell (MSC) therapy platform is being an “off the shelf” cell therapy for two clinical indications: the treatment of ischemic HFrEF (CardiALLO™), which is actively enrolling, and acute respiratory distress syndrome (ARDS).

Company Profile

SymbolBCDAW
Company NameBiocardia Inc C/Wts 06/08/2024(To Pur Com)
CEODr. Peter Altman, PhD
MarketNASDAQ
Employees20
Fiscal Year Ends12-31

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Peter Altman, PhD
  • Director, President and Chief Executive Officer
  • 746.24K
  • David McClung
  • Chief Financial Officer and Principal Accounting Officer
  • 469.47K
  • Edward M. Gillis
  • Senior Vice President, Devices
  • 326.37K
  • Andrew Scott Blank
  • Chairman of the Board
  • 97.79K
  • Dr. Richard M. Krasno, PhD
  • Independent Director
  • 57.79K
  • William Facteau
  • Independent Director
  • 24.69K
  • Jim L. Allen
  • Independent Director
  • 49.29K
  • Dr. Simon H. Stertzer, M.D.
  • Independent Director
  • 47.55K
  • Jay M. Moyes
  • Independent Director
  • 65.29K
Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.